Home

James Hassard, Chief Commercial Officer: Crinetics Pharmaceuticals CRNX Sell · Filed 24/06/24

Trade details

Type
Insider sale
Amount
$669,900
Shares · price
15,000 sh · $44.66 a share
Held after
29,259 sh
Trade date
24/06/21
Filed
24/06/24
Days to filing
3 days

Sold 33.9% of holdings

Share of holding sold
33.9%

Crinetics Pharmaceuticals trades, last 26 weeks

What else happened in Crinetics Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/05/22~24/07/21

James Hassard's recent trades

  • James Hassard

    Sell10b5-1 planCrinetics Pharmaceuticals

    $661.2K

    Filed 24/07/09